Plasma high density lipoproteins (HDL) are small, dense, protein-rich particles compared
with other lipoprotein classes; roughly half of total HDL mass is accounted for by lipid …

The metabolic syndrome (MetS) is comprised of a cluster of closely related risk factors,
including visceral adiposity, insulin resistance, hypertension, high triglyceride, and low high …

HDL is a major atheroprotective factor, but the mechanisms underlying this effect are still
obscure. HDL binding to scavenger receptor-BI has been shown to activate eNOS, although …

It is well recognized that high-density lipoprotein (HDL)-cholesterol is antiatherogenic and
serves a role in mediating cholesterol efflux from cells. However, HDL has multiple …

High-density lipoprotein (HDL) has been identified as a potential target in the treatment of
atherosclerotic vascular disease. The failure of torcetrapib, an inhibitor of cholesteryl ester …

Diet and obesity are important risk factors for cancer development. Many studies have
suggested an important role for several dietary nutrients in the progression and …

The concentration, composition, shape, and size of plasma high-density lipoprotein (HDL)
are determined by numerous proteins that influence its biogenesis, remodeling, and …

Lipid abnormalities are among the key risk factors for cardiovascular disease. Indeed, lipid-
modifying drugs—in particular, the statins, which primarily lower plasma levels of low …

Plasma high density lipoprotein (HDL) levels bear a strong independent inverse relationship
with atherosclerotic cardiovascular disease. Although HDL has anti‐oxidant, anti …

The endothelium is essential for the maintenance of vascular homeostasis. Central to this
role is the production of endothelium-derived nitric oxide (EDNO), synthesized by the …